Trade Celon Pharma SA - CLNP CFD

Trading Conditions

• Type: CFD
• Spread: 0.200
• Long position overnight funding adjustment: -0.02148%
• Short position overnight funding adjustment: -0.00044%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: PLN
• Min traded quantity: 0.1
• Margin: 20.00%
• Stock exchange: Poland
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 19.86
• Open: 19.64
• 1-Year Change: N/A
• Day's Range: 19.2 - 19.74

What is Celon Pharma SA (CLNP)?

Celon Pharma SA is a biopharmaceutical company engaged in the research, development, and commercialization of innovative medicinal products. It focuses on therapies for oncology, immunology, and other therapeutic areas. The company conducts clinical trials and collaborates with research institutions to advance its drug development pipeline. Celon Pharma SA also manages the manufacturing and marketing of pharmaceutical products, adhering to regulatory standards for quality and safety. It aims to address unmet medical needs by developing novel treatments. The company operates within the pharmaceutical industry ecosystem, contributing to healthcare advancements through scientific research and product innovation.

Celon Pharma SA Stock Price Today: Live Overview

The price today is shaped by current trading, where Allegro.eu SA trades at zł19.860. Its intraday price span covers zł19.14 to zł19.82, with a daily movement of -1.0081%.

FAQ: Celon Pharma SA (CLNP)

What is the current price of CLNP stock?

The price currently is zł19.860.

Does CLNP pay dividends?

Celon Pharma SA pays dividends to its shareholders.

Does CLNP have a formal corporate presence or regional headquarters in the UAE?

Celon Pharma SA does not have an official presence in the UAE and operates via distributors.

What is CLNP best known for?

Celon Pharma SA is most famous for developing and manufacturing pharmaceutical products.

What assets are typically shown together with CLNP?

Commonly shown alongside CLNP: iShares Trust - iShares MBS ETF, Standard Lithium Ltd, World Kinect Corp